By Editor , 30 September 2026
ITSM Market to Double to $22.91B by 2031 on AI Adoption

Delray Beach, Fla. – September 30, 2026 -- The global IT Service Management (ITSM) market is projected to grow from USD 10.96 billion in 2026 to USD 22.91 billion by 2031, a compound annual growth rate of 15.9%, according to MarketsandMarkets. The market stood at USD 9.41 billion in 2025, underscoring accelerating enterprise spending on hybrid IT and AI-enabled service delivery.

By Editor , 30 September 2026
Miter Raises $40M Series B to Fix Construction's 'Frankenstack' Tech

San Francisco – September 30, 2026 -- Miter, an AI-powered workforce management platform for the construction industry, has raised a $40 million Series B round led by Battery Ventures, pushing its total capital raised to $78 million. Existing backers Bessemer Venture Partners and Coatue also participated in the round.

By Editor , 30 September 2026

Paris – – September 30, 2026 -- The Generation Essentials Group (NYSE: TGE; LSE: TGE) reported net profit of US$22.8 million for the six months ended June 30, 2026, a 9.9-fold increase driven by an aggressive expansion of its global hotel portfolio.

By Editor , 30 September 2026
Virtus Solis, Brae Systems Sign First-Ever Space Solar PPA

Troy, Michigan and Chicago – September 30, 2026 -- Virtus Solis Technologies and Brae Systems have closed a 20-year Power Purchase Agreement for space-based solar power, marking the world's first commercial orbital solar PPA and a multi-billion-dollar lifetime contract commitment.

By Editor , 30 September 2026
Dar Global Revenue Jumps 66% to $258M as GDV Hits $23bn

Riyadh – September 30, 2026 -- Dar Global, the London-listed luxury developer, posted a 66% revenue increase to US$258.0 million for the six months ended June 30, 2026, up from US$155.4 million in HY 2025.

By Editor , 30 September 2026
Novo Nordisk: Wegovy Pill Switch Study Shows 8.8 lb Loss in 3 Months

Plainsboro, New Jersey – – September 30, 2026 -- Adults with overweight or obesity who switched from injectable GLP-1 therapies to the oral Wegovy pill lost an average of 4.0 kg (8.8 lb) over three months, according to new real-world data from Novo Nordisk's OCTANE study presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan on September 30, 2026.

By Editor , 30 September 2026
Astrocyte Raises $9.5M Series B as Concussion Drug Trial Completes Enrollment

Groton, Conn. – September 30, 2026 -- Astrocyte Pharmaceuticals Inc. has closed a $9.5 million Series B financing round to advance Phase 2 development of AST-004, its cerebroprotective therapy for concussion, traumatic brain injury (TBI) and stroke. The round brings total capital raised by the clinical-stage biotech, including grants, to $40 million.